An Expanded Treatment Protocol (ETP) of Midostaurin (PKC412) in Patients 18 Years of Age or Older With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia (AML)
about
An Expanded Treatment Protocol (ETP) of Midostaurin (PKC412) in Patients 18 Years of Age or Older With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia (AML)
description
clinical trial
@en
klinisch onderzoek
@nl
name
An Expanded Treatment Protocol ...... d Acute Myeloid Leukemia (AML)
@en
type
label
An Expanded Treatment Protocol ...... d Acute Myeloid Leukemia (AML)
@en
prefLabel
An Expanded Treatment Protocol ...... d Acute Myeloid Leukemia (AML)
@en
P1050
P1476
An Open-labeled, Multi-Center, ...... and Consolidation Chemotherapy
@en
P17
P3098
NCT03114228